User:RelentlessRecusant/RR8234

RR8234 is a bioactive small molecule compound, formally known under IUPAC nomenclature as sodium 3-bromo-4-(2-carbamoyl-6-(cyclopenta-1,3,-dienyl)-9-(3-hydroxyphenyl)-9H-purin-8-yl)cyclopentanolate. Its inorganic optimization would lead to the devising of Acuplanin (RR823490), the first cure for Type 1 Diabetes.